Literature DB >> 16800737

Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum.

Kristina Stefansson1, Maria Brattsand, Annelii Ny, Bo Glas, Torbjörn Egelrud.   

Abstract

We have previously presented evidence that two human kallikrein-related peptidases, KLK5 (hK5, stratum corneum tryptic enzyme, SCTE) and KLK7 (hK7, stratum corneum chymotryptic enzyme, SCCE), which are abundant in the stratum corneum, may be involved in desquamation. Since we had noted that not all trypsin-like activity in the plantar stratum corneum could be ascribed to KLK5, we set out to identify other skin proteases with similar primary substrate specificity. Here we describe purification of a protease identified as KLK14 from plantar stratum corneum, and show that this enzyme may be responsible for as much as 50% of the total trypsin-like activity in this tissue, measured as activity towards a chromogenic substrate cleaved by a wide variety of enzymes with trypsin-like specificity. This was in spite of very low levels of KLK14 protein compared to KLK5 and KLK7. KLK14 could be detected by immunoblotting in normal superficial stratum corneum of all individuals examined. The majority of KLK14 in the plantar stratum corneum is present in its catalytically active form. KLK14 could be immunohistochemically detected in sweat ducts, preferentially in the intraepidermal parts (the acrosyringium), and in sweat glands. The role played by this very efficient protease under normal and disease conditions in the skin remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16800737     DOI: 10.1515/BC.2006.095

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  11 in total

Review 1.  Involvement of corneodesmosome degradation and lamellar granule transportation in the desquamation process.

Authors:  Akemi Ishida-Yamamoto; Mari Kishibe
Journal:  Med Mol Morphol       Date:  2011-03-23       Impact factor: 2.309

Review 2.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

Review 3.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

4.  Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation.

Authors:  Masashi Miyai; Yuuko Matsumoto; Haruyo Yamanishi; Mami Yamamoto-Tanaka; Ryoji Tsuboi; Toshihiko Hibino
Journal:  J Invest Dermatol       Date:  2014-01-03       Impact factor: 8.551

5.  Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.

Authors:  Azza Eissa; Vanessa Amodeo; Christopher R Smith; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

6.  Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome.

Authors:  Katiuchia Uzzun Sales; Andrius Masedunskas; Alexandra L Bey; Amber L Rasmussen; Roberto Weigert; Karin List; Roman Szabo; Paul A Overbeek; Thomas H Bugge
Journal:  Nat Genet       Date:  2010-07-25       Impact factor: 38.330

Review 7.  Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

Authors:  Peter Goettig; Viktor Magdolen; Hans Brandstetter
Journal:  Biochimie       Date:  2010-07-06       Impact factor: 4.079

8.  Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin.

Authors:  Kimberly N Kanada; Teruaki Nakatsuji; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2012-02-16       Impact factor: 8.551

9.  Exploring Mouse Protein Function via Multiple Approaches.

Authors:  Guohua Huang; Chen Chu; Tao Huang; Xiangyin Kong; Yunhua Zhang; Ning Zhang; Yu-Dong Cai
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

10.  Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome.

Authors:  Laetitia Furio; Simon de Veer; Madeleine Jaillet; Anais Briot; Aurelie Robin; Celine Deraison; Alain Hovnanian
Journal:  J Exp Med       Date:  2014-02-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.